
Lida Hariri
Associate Professor of Pathology · Harvard Medical School
Credentials: · · · ·
History
- Present
- 2012–2013
Research
Three subtypes of lung cancer fibroblasts define distinct therapeutic paradigms
Cancer Cell · 2021 · 223 citations
Developmental Cell · 2014 · 191 citations
Nano-optic endoscope for high-resolution optical coherence tomography in vivo
Nature Photonics · 2018 · 179 citations
- MM
34 papers
- AS
17 papers

17 papers

16 papers

15 papers
- CR
15 papers

15 papers

15 papers
Grants
- 2026–2030
Optical Imaging Biomarker to Predict Disease Outcomes in Pulmonary Fibrosis
National Heart, Lung, and Blood Institute · R01
Contact PI · $1.7M · Massachusetts General Hospital
- 2024–2029
Microscopic EB-OCT Imaging to Predict Progression in Interstitial Lung Abnormalities
National Heart, Lung, and Blood Institute · R01
Contact PI · $2.5M · Massachusetts General Hospital
- 2020–2027
In vivo Endobronchial OCT for IPF Diagnosis and Therapy Response Assessment
National Heart, Lung, and Blood Institute · R01
Contact PI · $4M · Massachusetts General Hospital
- 2016–2021
Low Risk in vivo Diagnosis of IPF with Optical Imaging
National Heart, Lung, and Blood Institute · K23
Contact PI · $895.9K · Massachusetts General Hospital
